Why Veracyte (VCYT) is Poised to Beat Earnings Estimates Again [Yahoo! Finance]
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Yahoo! Finance
It is worth considering Veracyte (VCYT), which belongs to the Zacks Medical - Instruments industry. When looking at the last two reports, this molecular diagnostic company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 50.66%, on average, in the last two quarters. For the last reported quarter, Veracyte came out with earnings of $0.51 per share versus the Zacks Consensus Estimate of $0.32 per share, representing a surprise of 59.38%. For the previous quarter, the company was expected to post earnings of $0.31 per share and it actually produced earnings of $0.44 per share, delivering a surprise of 41.94%. With this earnings history in mind, recent estimates have been moving higher for Veracyte. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the company is positive, which is a great sign of an earnings beat, especially when you combine this metric with its nice Zacks Rank. Our research shows that stocks with
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Veracyte: Profitable, De-Risked, And Ready To Run [Seeking Alpha]Seeking Alpha
- Veracyte (NASDAQ:VCYT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- Veracyte (NASDAQ:VCYT) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results [Yahoo! Finance]Yahoo! Finance
- Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 ResultsBusiness Wire
VCYT
Earnings
- 11/4/25 - Beat
VCYT
Sec Filings
- 1/12/26 - Form 8-K
- 1/8/26 - Form SCHEDULE
- 12/17/25 - Form 4
- VCYT's page on the SEC website